Incyte (INCY) Current Deferred Revenue (2016)
Incyte (INCY) has disclosed Current Deferred Revenue for 7 consecutive years, with $2.9 million as the latest value for Q3 2016.
- For the quarter ending Q3 2016, Current Deferred Revenue fell 77.69% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Sep 2016, down 77.69%, and an annual FY2015 reading of $12.5 million, down 2.86% over the prior year.
- Current Deferred Revenue was $2.9 million for Q3 2016 at Incyte, down from $6.1 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $67.0 million in Q3 2012 and bottomed at $2.9 million in Q3 2016.
- Average Current Deferred Revenue over 5 years is $21.0 million, with a median of $12.9 million recorded in 2014.
- The sharpest move saw Current Deferred Revenue tumbled 91.03% in 2012, then surged 775.17% in 2013.
- Year by year, Current Deferred Revenue stood at $66.1 million in 2012, then crashed by 80.49% to $12.9 million in 2013, then dropped by 0.08% to $12.9 million in 2014, then fell by 2.86% to $12.5 million in 2015, then tumbled by 77.08% to $2.9 million in 2016.
- Business Quant data shows Current Deferred Revenue for INCY at $2.9 million in Q3 2016, $6.1 million in Q2 2016, and $9.3 million in Q1 2016.